Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | HTR3A | P46098 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4258315 | 1.00 | TAAR1 (0.52) | TAAR1NFKB1HIF1AHTR3ATSHR | |
| SCHEMBL13569326 | 1.00 | TAAR1 (0.52) | TAAR1NFKB1HIF1AHTR3ATSHR | |
| SCHEMBL11125287 | 0.81 | ESR1 (0.45) | TAAR1NFKB1HIF1AHTR3ATSHR | |
| SCHEMBL28602145 | 0.81 | ESR1 (0.56) | TAAR1NFKB1HIF1AHTR3ATSHR | |
| SCHEMBL18257696 | 0.81 | AOC3 (0.42) | TAAR1NFKB1TDP1CYP1A2MAPT | |
| SCHEMBL13569341 | 0.81 | AOC3 (0.42) | TAAR1NFKB1TDP1CYP1A2MAPT | |
| SCHEMBL13569343 | 0.81 | AOC3 (0.42) | TAAR1NFKB1TDP1CYP1A2MAPT | |
| SCHEMBL12454628 | 0.79 | AOC3 (0.62) | CYP2D6SLC6A2SLC6A3AOC3GRIN1 | |
| SCHEMBL13569328 | 0.79 | AOC3 (0.62) | TAAR1TSHRTDP1CYP1A2CYP3A4 | |
| SCHEMBL7699744 | 0.79 | HTR2A (0.48) | TAAR1CYP1A2CHRM2CHRM1DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632972-B2 | Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLIONIS (US) | 2009-12-15 | — | — | US | disclosed |
| US-7632972-B2 | Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLIONIS (US) | 2009-12-15 | — | — | US | disclosed |
| US-7632972-B2 | Reacting an acid and an amine; apoptosis; carbamate, and N-phenethyl-2-phenylacetamide | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLIONIS (US) | 2009-12-15 | — | — | US | disclosed |
| US-20050197511-A1 | Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells | NATIONAL SCIENCE FOUNDATION | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197511-A1 | Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells | BAD, MCL1, CASP3 | TAAR1 4480/4885NFKB1 2538/4885HIF1A 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.